This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 26, 2012 8:30 am ET
Coleman N. Lannum - Vice President of Investor Relations
Jose E. Almeida - Chairman of the Board, Chief Executive Officer and President
Charles J. Dockendorff - Chief Financial Officer and Executive Vice President
David H. Roman - Goldman Sachs Group Inc., Research Division
David R. Lewis - Morgan Stanley, Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Robert A. Hopkins - BofA Merrill Lynch, Research Division
Matthew J. Dodds - Citigroup Inc, Research Division
Thomas J. Gunderson - Piper Jaffray Companies, Research Division
Joanne K. Wuensch - BMO Capital Markets U.S.
Matthew O'Brien - William Blair & Company L.L.C., Research Division
Matthew Taylor - Barclays Capital, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Lawrence S. Keusch - Raymond James & Associates, Inc., Research Division
Anthony Petrone - Jefferies & Company, Inc., Research Division
Jonathan J. Palmer - Credit Agricole Securities (USA) Inc., Research Division
Good day, ladies and gentlemen, and welcome to the Q3 2012 Covidien plc Earnings Conference Call. My name is Clinton, and I'll be your operator for today. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. And now, I'd like to turn the call over to Cole Lannum, Vice President of Investor Relations. Please proceed, sir.
Coleman N. Lannum
Thanks, Clinton, and good morning, everyone. With me today are Joe Almeida, Covidien's Chairman, President and CEO; and Chuck Dockendorff, our Chief Financial Officer.